ELI LILLY & CO (LLY.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:LLY - US5324571083 - Common Stock
947.3 EUR
-3.8 (-0.4%)
Overall LLY gets a fundamental rating of 6 out of 10. We evaluated LLY against 55 industry peers in the Pharmaceuticals industry. LLY scores excellent on profitability, but there are some minor concerns on its financial health. LLY is valued quite expensive, but it does show an excellent growth. With these ratings, LLY could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
LLY had positive earnings in the past year.
LLY had a positive operating cash flow in the past year.
Each year in the past 5 years LLY has been profitable.
Each year in the past 5 years LLY had a positive operating cash flow.
1.2 Ratios
LLY's Return On Assets of 16.02% is amongst the best of the industry. LLY outperforms 89.09% of its industry peers.
With an excellent Return On Equity value of 77.38%, LLY belongs to the best of the industry, outperforming 96.36% of the companies in the same industry.
LLY has a better Return On Invested Capital (28.84%) than 94.55% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LLY is significantly above the industry average of 14.90%.
The 3 year average ROIC (21.71%) for LLY is below the current ROIC(28.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROIC | 28.84% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
1.3 Margins
LLY's Profit Margin of 30.99% is amongst the best of the industry. LLY outperforms 96.36% of its industry peers.
LLY's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 44.41%, LLY belongs to the best of the industry, outperforming 96.36% of the companies in the same industry.
LLY's Operating Margin has improved in the last couple of years.
LLY has a Gross Margin of 83.03%. This is amongst the best in the industry. LLY outperforms 85.45% of its industry peers.
In the last couple of years the Gross Margin of LLY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% |
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
LLY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, LLY has about the same amount of shares outstanding.
The number of shares outstanding for LLY has been reduced compared to 5 years ago.
Compared to 1 year ago, LLY has a worse debt to assets ratio.
2.2 Solvency
LLY has an Altman-Z score of 8.64. This indicates that LLY is financially healthy and has little risk of bankruptcy at the moment.
LLY has a Altman-Z score of 8.64. This is amongst the best in the industry. LLY outperforms 96.36% of its industry peers.
The Debt to FCF ratio of LLY is 6.60, which is on the high side as it means it would take LLY, 6.60 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.60, LLY is doing worse than 63.64% of the companies in the same industry.
LLY has a Debt/Equity ratio of 1.72. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.72, LLY is doing worse than 76.36% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Altman-Z | 8.64 |
ROIC/WACC3.29
WACC8.76%
2.3 Liquidity
A Current Ratio of 1.55 indicates that LLY should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.55, LLY is in the better half of the industry, outperforming 61.82% of the companies in the same industry.
A Quick Ratio of 1.24 indicates that LLY should not have too much problems paying its short term obligations.
LLY has a Quick ratio of 1.24. This is in the better half of the industry: LLY outperforms 69.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 116.22% over the past year.
LLY shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.57% yearly.
LLY shows a strong growth in Revenue. In the last year, the Revenue has grown by 45.41%.
Measured over the past years, LLY shows a quite strong growth in Revenue. The Revenue has been growing by 15.08% on average per year.
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
3.2 Future
The Earnings Per Share is expected to grow by 30.75% on average over the next years. This is a very strong growth
Based on estimates for the next years, LLY will show a quite strong growth in Revenue. The Revenue will grow by 18.43% on average per year.
EPS Next Y80.9%
EPS Next 2Y54.64%
EPS Next 3Y42.29%
EPS Next 5Y30.75%
Revenue Next Year38.67%
Revenue Next 2Y28.28%
Revenue Next 3Y23.95%
Revenue Next 5Y18.43%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 49.88, the valuation of LLY can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of LLY indicates a slightly more expensive valuation: LLY is more expensive than 63.64% of the companies listed in the same industry.
LLY is valuated expensively when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 35.28, LLY can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, LLY is valued a bit more expensive than the industry average as 65.45% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 36.12. LLY is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 49.88 | ||
| Fwd PE | 35.28 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LLY is valued a bit more expensive than the industry average as 70.91% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, LLY is valued a bit more expensive than the industry average as 69.09% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 161.27 | ||
| EV/EBITDA | 37.99 |
4.3 Compensation for Growth
LLY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LLY has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as LLY's earnings are expected to grow with 42.29% in the coming years.
PEG (NY)0.62
PEG (5Y)3.01
EPS Next 2Y54.64%
EPS Next 3Y42.29%
5. Dividend
5.1 Amount
LLY has a yearly dividend return of 0.58%, which is pretty low.
Compared to an average industry Dividend Yield of 3.00, LLY has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.41, LLY's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.58% |
5.2 History
On average, the dividend of LLY grows each year by 15.59%, which is quite nice.
Dividend Growth(5Y)15.59%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
28.28% of the earnings are spent on dividend by LLY. This is a low number and sustainable payout ratio.
LLY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.28%
EPS Next 2Y54.64%
EPS Next 3Y42.29%
FRA:LLY (11/27/2025, 7:00:00 PM)
947.3
-3.8 (-0.4%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners83.75%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap896.58B
Revenue(TTM)59.42B
Net Income(TTM)18.41B
Analysts80
Price Target880.84 (-7.02%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.58% |
Yearly Dividend4.28
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)14.51%
Max EPS beat(2)22.05%
EPS beat(4)4
Avg EPS beat(4)13.1%
Min EPS beat(4)6.45%
Max EPS beat(4)22.05%
EPS beat(8)7
Avg EPS beat(8)12.06%
EPS beat(12)10
Avg EPS beat(12)23.73%
EPS beat(16)13
Avg EPS beat(16)17.41%
Revenue beat(2)2
Avg Revenue beat(2)6.77%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.81%
Revenue beat(4)2
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.81%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)7
Avg Revenue beat(12)2.64%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)14.66%
PT rev (3m)14.89%
EPS NQ rev (1m)1.97%
EPS NQ rev (3m)2.68%
EPS NY rev (1m)3.7%
EPS NY rev (3m)2.29%
Revenue NQ rev (1m)1.67%
Revenue NQ rev (3m)1.92%
Revenue NY rev (1m)1.44%
Revenue NY rev (3m)1.3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 49.88 | ||
| Fwd PE | 35.28 | ||
| P/S | 17.47 | ||
| P/FCF | 161.27 | ||
| P/OCF | 64.62 | ||
| P/B | 43.62 | ||
| P/tB | 90.66 | ||
| EV/EBITDA | 37.99 |
EPS(TTM)18.99
EY2%
EPS(NY)26.85
Fwd EY2.83%
FCF(TTM)5.87
FCFY0.62%
OCF(TTM)14.66
OCFY1.55%
SpS54.23
BVpS21.71
TBVpS10.45
PEG (NY)0.62
PEG (5Y)3.01
Graham Number96.32
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROCE | 35.28% | ||
| ROIC | 28.84% | ||
| ROICexc | 33.25% | ||
| ROICexgc | 41.06% | ||
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% | ||
| FCFM | 10.83% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexgc growth 3Y1.59%
ROICexgc growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.82%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Debt/EBITDA | 1.44 | ||
| Cap/Depr | 507.66% | ||
| Cap/Sales | 16.2% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.78% | ||
| Profit Quality | 34.96% | ||
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 8.64 |
F-Score7
WACC8.76%
ROIC/WACC3.29
Cap/Depr(3y)385.26%
Cap/Depr(5y)286.02%
Cap/Sales(3y)16.93%
Cap/Sales(5y)13.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
EPS Next Y80.9%
EPS Next 2Y54.64%
EPS Next 3Y42.29%
EPS Next 5Y30.75%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
Revenue Next Year38.67%
Revenue Next 2Y28.28%
Revenue Next 3Y23.95%
Revenue Next 5Y18.43%
EBIT growth 1Y82.81%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year93.86%
EBIT Next 3Y42.49%
EBIT Next 5Y30.03%
FCF growth 1Y4003.21%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y158.46%
OCF growth 3Y6.69%
OCF growth 5Y12.76%
ELI LILLY & CO / LLY.DE FAQ
What is the fundamental rating for LLY stock?
ChartMill assigns a fundamental rating of 6 / 10 to LLY.DE.
What is the valuation status for LLY stock?
ChartMill assigns a valuation rating of 3 / 10 to ELI LILLY & CO (LLY.DE). This can be considered as Overvalued.
What is the profitability of LLY stock?
ELI LILLY & CO (LLY.DE) has a profitability rating of 9 / 10.
What is the financial health of ELI LILLY & CO (LLY.DE) stock?
The financial health rating of ELI LILLY & CO (LLY.DE) is 5 / 10.
What is the expected EPS growth for ELI LILLY & CO (LLY.DE) stock?
The Earnings per Share (EPS) of ELI LILLY & CO (LLY.DE) is expected to grow by 80.9% in the next year.